KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Return on Sales (2016 - 2025)

Merck (MRK) has disclosed Return on Sales for 17 consecutive years, with 0.18% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales fell 6.0% to 0.18% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.28%, a 1.0% increase, with the full-year FY2025 number at 0.28%, up 1.0% from a year prior.
  • Return on Sales was 0.18% for Q4 2025 at Merck, down from 0.33% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.34% in Q2 2024 to a low of 0.4% in Q2 2023.
  • A 5-year average of 0.12% and a median of 0.18% in 2025 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: tumbled -40bps in 2023, then skyrocketed 74bps in 2024.
  • Merck's Return on Sales stood at 0.0% in 2021, then skyrocketed by 77bps to 0.0% in 2022, then tumbled by -8017bps to 0.08% in 2023, then skyrocketed by 395bps to 0.24% in 2024, then decreased by -25bps to 0.18% in 2025.
  • Per Business Quant, the three most recent readings for MRK's Return on Sales are 0.18% (Q4 2025), 0.33% (Q3 2025), and 0.28% (Q2 2025).